Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

NCT00869206 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1822

Enrollment

OTHER

Sponsor class

Conditions

Breast Adenocarcinoma
DS Stage I Plasma Cell Myeloma
DS Stage II Plasma Cell Myeloma
Metastatic Malignant Neoplasm to the Bone
Pain
Musculoskeletal Complication
Urinary Complications

Interventions

DRUG: zoledronic acid

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]